|
Market Closed -
Nasdaq
16:00:00 2026-08-19 EDT
|
5-day change | 1st Jan Change | ||
| 2.230 USD | +9.85% |
|
+5.19% | +62.77% |
| 08-13 | Allogene Therapeutics Remains Attractive Given Valuation, Clinical Strategy, RBC Says | MT |
| 08-12 | Allogene Therapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +9.85% | +5.19% | +24.58% | +14.95% | +62.77% | +104.59% | -43.54% | -89.75% | - | 701M | |
| -1.90% | +2.37% | +39.11% | +60.71% | +80.94% | +69.11% | +110.88% | +27.51% | - | 73.45B | |
| +0.87% | +17.17% | +16.70% | +29.90% | +22.43% | +53.05% | +95.59% | +226.97% | +6,352.94% | 62.99B | |
| +1.71% | -1.44% | +20.62% | +21.94% | -24.93% | +2.66% | +501.29% | +472.82% | +949.48% | 28.05B | |
| -1.40% | +4.18% | +29.53% | +45.42% | +52.35% | +54.52% | +19.60% | -57.46% | - | 25.42B | |
| +21.96% | +21.90% | +23.66% | +27.32% | +18.82% | +0.51% | +2.50% | -68.92% | - | 23.3B | |
| +2.28% | +7.98% | +15.14% | +27.30% | +6.17% | +42.75% | -12.34% | -27.79% | +97.07% | 19.45B | |
| 0.00% | -4.11% | +17.15% | +92.68% | +230.42% | +243.99% | +423.83% | +1,733.40% | +857.44% | 18.16B | |
| -3.50% | -0.95% | +7.63% | +23.41% | +33.48% | +17.17% | +534.55% | - | - | 16.53B | |
| +2.39% | +5.96% | -2.74% | +9.13% | +24.09% | +44.04% | +157.77% | +197.86% | +395.81% | 13.16B | |
| +1.72% | +0.19% | +20.34% | +20.91% | +34.67% | +349.07% | +216.38% | +49.59% | +1,166.43% | 12.42B | |
| +3.01% | +0.91% | -2.41% | +3.43% | -7.24% | +38.00% | +200.52% | +568.60% | +5,796.94% | 12.12B | |
| -1.87% | -12.37% | +1.08% | -21.53% | -20.97% | -47.99% | +174.77% | +117.01% | - | 10.69B | |
| +2.16% | +1.69% | -3.04% | +3.41% | +22.35% | +99.59% | +139.64% | +156.99% | +553.28% | 10.58B | |
| +2.26% | -13.26% | -5.07% | -18.16% | -25.04% | -50.13% | +644.89% | +83.61% | +88.01% | 10.23B | |
| +1.02% | +6.02% | +8.67% | +55.42% | +232.48% | +542.98% | +789.14% | -36.40% | -25.90% | 9.51B | |
| -1.52% | -6.87% | +2.23% | -9.15% | +8.26% | -3.05% | +118.65% | -26.11% | - | 9.1B | |
| -0.04% | +0.39% | +0.99% | +144.06% | +81.93% | +184.77% | +424.72% | +292.63% | - | 8.99B | |
| +5.87% | +6.89% | +12.63% | +30.68% | +37.19% | +97.26% | +27.06% | +175.34% | - | 8.9B | |
| +5.31% | +6.97% | +5.86% | +1.62% | +310.61% | +234.57% | +349.17% | -13.05% | - | 8.18B | |
| Average | +2.27% | -0.35% | +11.63% | +28.17% | +59.04% | +103.87% | +243.75% | +199.10% | +1,623.15% | 19.1B | |
| Weighted average by Cap. | +1.57% | +2.44% | +18.18% | +35.15% | +51.43% | +79.84% | +203.39% | +204.64% | +2,749.37% |
- Stock Market
- Stocks
- ALLO Stock
- Sector Allogene Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
